These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19679205)

  • 1. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
    Pereira RC; Juppner H; Azucena-Serrano CE; Yadin O; Salusky IB; Wesseling-Perry K
    Bone; 2009 Dec; 45(6):1161-8. PubMed ID: 19679205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-23 in bone biology.
    Wesseling-Perry K
    Pediatr Nephrol; 2010 Apr; 25(4):603-8. PubMed ID: 20012997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
    Imanishi Y; Hashimoto J; Ando W; Kobayashi K; Ueda T; Nagata Y; Miyauchi A; Koyano HM; Kaji H; Saito T; Oba K; Komatsu Y; Morioka T; Mori K; Miki T; Inaba M
    J Bone Miner Metab; 2012 Jan; 30(1):93-9. PubMed ID: 21739089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.
    Pereira RC; Jüppner H; Gales B; Salusky IB; Wesseling-Perry K
    PLoS One; 2015; 10(3):e0120856. PubMed ID: 25774916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone.
    Nampei A; Hashimoto J; Hayashida K; Tsuboi H; Shi K; Tsuji I; Miyashita H; Yamada T; Matsukawa N; Matsumoto M; Morimoto S; Ogihara T; Ochi T; Yoshikawa H
    J Bone Miner Metab; 2004; 22(3):176-84. PubMed ID: 15108058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEPE Localization in the Craniofacial Complex and Function in Tooth Dentin Formation.
    Gullard A; Gluhak-Heinrich J; Papagerakis S; Sohn P; Unterbrink A; Chen S; MacDougall M
    J Histochem Cytochem; 2016 Apr; 64(4):224-36. PubMed ID: 26927967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
    Kyono A; Avishai N; Ouyang Z; Landreth GE; Murakami S
    J Bone Miner Metab; 2012 Jan; 30(1):19-30. PubMed ID: 21678127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia.
    Habra MA; Jimenez C; Huang SC; Cote GJ; Murphy WA; Gagel RF; Hoff AO
    Endocr Pract; 2008 Dec; 14(9):1108-14. PubMed ID: 19158050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unified model for bone-renal mineral and energy metabolism.
    Rowe PS
    Curr Opin Pharmacol; 2015 Jun; 22():64-71. PubMed ID: 25880364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
    Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
    J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium‑dependent activation of PHEX, MEPE and DMP1 in osteocytes.
    Donmez BO; Karagur ER; Donmez AC; Choi J; Akkus O
    Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36281920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein Levels in Healthy Children and, Pregnant and Puerperal Women.
    Ozsen A; Furman A; Guran T; Bereket A; Turan S
    Horm Res Paediatr; 2019; 92(5):302-310. PubMed ID: 32187608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteocyte and DMP1].
    Toyosawa S; Oya K; Sato S; Ishida K
    Clin Calcium; 2012 May; 22(5):713-20. PubMed ID: 22549196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
    Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
    Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of dentin matrix protein 1 (Dmp1) phosphorylation by Fam20C in bone: implications for the induction of biomineralization.
    Oya K; Ishida K; Nishida T; Sato S; Kishino M; Hirose K; Ogawa Y; Ikebe K; Takeshige F; Yasuda H; Komori T; Toyosawa S
    Histochem Cell Biol; 2017 Mar; 147(3):341-351. PubMed ID: 27614627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
    Zhang GX; Mizuno M; Tsuji K; Tamura M
    Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.
    Zelenchuk LV; Hedge AM; Rowe PS
    Bone; 2015 Oct; 79():131-42. PubMed ID: 26051469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone and heart health in chronic kidney disease: role of dentin matrix protein 1.
    Martin A
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):297-303. PubMed ID: 31107286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.